Engineering Biomaterial Properties to Modulate Adipocyte Phenotype
工程生物材料特性调节脂肪细胞表型
基本信息
- 批准号:2310739
- 负责人:
- 金额:$ 54万
- 依托单位:
- 依托单位国家:美国
- 项目类别:Standard Grant
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-08-01 至 2026-07-31
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
The number of people in the US that are classified as obese is almost 50% of the population, and that number is expected to rise. Obesity contributes to a state of continuous inflammation in fat tissue, and this inflammation increases the risk factor for conditions such as heart disease, type 2 diabetes, and stroke. Although there is a growing epidemic of obesity, there is limited understanding of how the support material outside of the cell affects the disease state of fat cells. This project investigates the effect of the tissue components and stiffness on the contributing response of fat cells toward inflammation. This knowledge will allow the team of investigators to make tissue mimics that can be used to develop therapies to treat obesity and the inflammation that occurs. This research will be used to recruit students from underrepresented groups and will provide multidisciplinary training in biology, biochemistry, and materials engineering. Outreach activities include developing new laboratory modules for female high school students who attend programs hosted by the Women in Engineering Program at Purdue University. During obesity, hypertrophic adipocytes secrete pro-inflammatory cytokines that can cause changes in the extracellular matrix (ECM) and contribute to a host of disease conditions. Recent studies show that the composition of the ECM can be used to cause normal adipocytes to transition into a diseased phenotype. Conversely, the ECM can be used to rescue adipocyte dysfunction and revert them to a healthy phenotype. Experiments described herein will examine the interactions between the biochemical composition and the biophysical properties of the ECM and their effect on adipocyte dysfunction. The research begins by defining the effect that hyaluronic acid avidity has on obesity-related adipocyte dysfunction (Objective #1). Next, the effect that stress relaxation and stiffness have on adipocyte dysfunction will be determined (Objective #2). Finally, the interplay between ligand-induced avidity, stress relaxation, and stiffness have on adipocyte dysfunction will be evaluated in order to understand the weighted contribution that each factor plays (Objective #3). Taken together, this work will show how changes in the microenvironment provide cues that guide adipocyte function and will establish a defined model to better understand drivers of obesity.This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the Foundation's intellectual merit and broader impacts review criteria.
美国被归类为肥胖的人数几乎占人口的50%,预计这一数字还会上升。肥胖导致脂肪组织持续炎症,这种炎症增加了心脏病、2型糖尿病和中风等疾病的风险因素。虽然肥胖症的流行越来越普遍,但对细胞外的支持材料如何影响脂肪细胞的疾病状态的理解有限。 本项目研究组织成分和硬度对脂肪细胞对炎症的贡献反应的影响。 这些知识将使研究人员能够制造组织模拟物,用于开发治疗肥胖和炎症的疗法。 这项研究将用于招收学生从代表性不足的群体,并将提供生物学,生物化学和材料工程的多学科培训。 外联活动包括为参加普渡大学妇女工程方案主办的方案的女高中生开发新的实验室模块。 在肥胖期间,肥大脂肪细胞分泌促炎细胞因子,其可引起细胞外基质(ECM)的变化并促成许多疾病状况。 最近的研究表明,ECM的组成可用于导致正常脂肪细胞转变为患病表型。相反,ECM可用于挽救脂肪细胞功能障碍并将其恢复为健康表型。 本文所述的实验将检查ECM的生物化学组成和生物物理性质之间的相互作用及其对脂肪细胞功能障碍的影响。该研究首先确定透明质酸亲和力对肥胖相关脂肪细胞功能障碍的影响(目标#1)。 接下来,将确定应力松弛和刚度对脂肪细胞功能障碍的影响(目标#2)。 最后,将评价配体诱导的亲合力、应力松弛和刚度对脂肪细胞功能障碍的相互作用,以了解每个因素的加权贡献(目标3)。 总之,这项工作将显示微环境的变化如何提供指导脂肪细胞功能的线索,并将建立一个定义的模型,以更好地了解肥胖的驱动因素。该奖项反映了NSF的法定使命,并已被认为值得通过使用基金会的智力价值和更广泛的影响审查标准进行评估的支持。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Julie Liu其他文献
Crisis-Counselor Perceptions of Job Training, Stress, and Satisfaction During Disaster Recovery
危机咨询师对灾难恢复期间工作培训、压力和满意度的看法
- DOI:
- 发表时间:
2019 - 期刊:
- 影响因子:0
- 作者:
N. Bellamy;M. Wang;Lori McGee;Julie Liu;M. Robinson - 通讯作者:
M. Robinson
Development of Assays to Support Identification and Characterization of Modulators of DExH-Box Helicase DHX9.
开发检测方法以支持 DExH-Box 解旋酶 DHX9 调节剂的识别和表征。
- DOI:
10.1016/j.slasd.2023.08.006 - 发表时间:
2023 - 期刊:
- 影响因子:0
- 作者:
D. Gotur;April W. Case;Julie Liu;E. Sickmier;Nicholas Holt;K. Knockenhauer;S. Yao;Young;R. Copeland;Shane M. Buker;P. Boriack - 通讯作者:
P. Boriack
A fast VQ codebook generation algorithm using codeword displacement
一种基于码字位移的快速VQ码本生成算法
- DOI:
10.1016/j.patcog.2007.04.015 - 发表时间:
2008 - 期刊:
- 影响因子:0
- 作者:
J. Z. Lai;Y. Liaw;Julie Liu - 通讯作者:
Julie Liu
Discovery of 2,4-1H-Imidazole Carboxamides as Potent and Selective TAK1 Inhibitors.
发现 2,4-1H-咪唑甲酰胺作为有效的选择性 TAK1 抑制剂。
- DOI:
- 发表时间:
2021 - 期刊:
- 影响因子:4.2
- 作者:
J. Veerman;Y. B. Bruseker;Eddy Damen;E. Heijne;W. van Bruggen;Koen F W Hekking;Robert Winkel;C. Hupp;Anthony D. Keefe;Julie Liu;H. Thomson;Ying Zhang;J. Cuozzo;Andrew J. Mcriner;M. Mulvihill;P. van Rijnsbergen;B. Zech;L. Renzetti;L. Babiss;G. Müller - 通讯作者:
G. Müller
The Prevalence of Co-morbidities in Adult and Adolescent Bariatric Surgery Candidates
成人和青少年减肥手术候选人合并症的患病率
- DOI:
- 发表时间:
2020 - 期刊:
- 影响因子:2.9
- 作者:
Julie Liu;J. W. Woo Baidal;I. Fennoy;Kristina Parkinson;Lori J. Lynch;J. Zitsman - 通讯作者:
J. Zitsman
Julie Liu的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Julie Liu', 18)}}的其他基金
Deconstructing and Reconstructing Oyster Cement to Create Inorganic Adhesives
解构和重建牡蛎水泥以制造无机粘合剂
- 批准号:
2104783 - 财政年份:2021
- 资助金额:
$ 54万 - 项目类别:
Standard Grant
Protein-based Materials with Tunable Adhesive and Mechanical Properties
具有可调粘合性和机械性能的蛋白质材料
- 批准号:
1309787 - 财政年份:2013
- 资助金额:
$ 54万 - 项目类别:
Standard Grant
BRIGE: Peptide-Based Cues for Mesenchymal Stem Cell Differentiation in Cartilage Graft Applications
BRIGE:软骨移植应用中间充质干细胞分化的基于肽的线索
- 批准号:
0927100 - 财政年份:2009
- 资助金额:
$ 54万 - 项目类别:
Standard Grant
相似海外基金
Regenerative biomaterial patches for failing hearts
用于衰竭心脏的再生生物材料贴片
- 批准号:
MR/X024210/1 - 财政年份:2024
- 资助金额:
$ 54万 - 项目类别:
Fellowship
SBIR Phase I: A Novel Carbon-Sequestering Biomaterial for Dropped Ceiling Tiles
SBIR 第一阶段:用于吊顶瓷砖的新型碳封存生物材料
- 批准号:
2304384 - 财政年份:2023
- 资助金额:
$ 54万 - 项目类别:
Standard Grant
A human tissue-engineered three-layer cornea (hTEC) supplemented with macrophages as a biomaterial for in vitro studies
补充有巨噬细胞的人体组织工程三层角膜(hTEC)作为体外研究的生物材料
- 批准号:
488980 - 财政年份:2023
- 资助金额:
$ 54万 - 项目类别:
Operating Grants
System for Annulus Fibrosus Repair (SAFR) – a percutaneously implantable preformed biomaterial for the repair of defects caused by either degenerative disc disease or needle puncture during nucleus pulposus replacement procedures SAFR
纤维环修复系统 (SAFR) — 一种可经皮植入的预制生物材料,用于修复髓核置换手术期间因椎间盘退行性疾病或针刺造成的缺陷
- 批准号:
10051703 - 财政年份:2023
- 资助金额:
$ 54万 - 项目类别:
Collaborative R&D
Development of a novel biomaterial model of collagen mediated genetic disease for study of collagen organisation and drug development
开发胶原蛋白介导的遗传病的新型生物材料模型,用于研究胶原蛋白组织和药物开发
- 批准号:
2897511 - 财政年份:2023
- 资助金额:
$ 54万 - 项目类别:
Studentship
Immunomodulatory biomaterial to enhancing T-cell responses to triple negative breast cancer
免疫调节生物材料可增强 T 细胞对三阴性乳腺癌的反应
- 批准号:
10699815 - 财政年份:2023
- 资助金额:
$ 54万 - 项目类别:
Bacterial Adhesion Inhibition and Biofilm Disruption by Adaptive Piezoelectric Biomaterial
自适应压电生物材料抑制细菌粘附和破坏生物膜
- 批准号:
10668030 - 财政年份:2023
- 资助金额:
$ 54万 - 项目类别:
Highly Elastic Biomaterial Development for Urethral Application
尿道应用的高弹性生物材料开发
- 批准号:
10573094 - 财政年份:2023
- 资助金额:
$ 54万 - 项目类别:
Biomaterial Manufacturing Suite in Support of NIH/NIAID and the Global Infectious Disease Research Community
支持 NIH/NIAID 和全球传染病研究界的生物材料制造套件
- 批准号:
10795293 - 财政年份:2023
- 资助金额:
$ 54万 - 项目类别:
Mitigating the Immunogenicity of Engineered Aav Gene Delivery Vectors by Biomaterial-Driven Immunosuppression
通过生物材料驱动的免疫抑制减轻工程化 Aav 基因递送载体的免疫原性
- 批准号:
10741139 - 财政年份:2023
- 资助金额:
$ 54万 - 项目类别: